Bethyl Laboratories
Rabbit anti-Nucleolin (NCL) IHC Antibody Affinity Purified
Primary
Catalog #IHC-00083
TargetNucleolin/NCL
HostRabbit
ClonalityPolyclonal
ReactivityMouse, Human
ApplicationIHC
Image 1 of 2
local_shipping
Order within 10 hours and 19 minutes for shipment by Tuesday, November 24
Product Description
Nucleolin (NCL) is a major nucleolar phosphoprotein that is involved in pre-RNA transcription and the synthesis and maturation of ribosomes. NCL can bind to histone H1 to induce chromatin condensation and may play an additional role in transcriptional elongation.
Specifications
Clonality
Polyclonal
Host
Rabbit
Immunogen
Between 660 and C-terminus
Isotype
IgG
Reactivity
Mouse, Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Antigen Affinity Purified
Concentration
50 µg/ml
Target Identity
TargetNucleolin/NCL
Antigen Species
Human
Gene ID4691
Gene Symbol
NCL
Gene Name
nucleolin
Uniprot IDP19338
Protein Name
Nucleolin
Alternate Names
C23 • Nsr1 • nucleolin • Protein C23
Product Information
Applications
IHC
Buffer
Tris-buffered Saline containing 0.1% BSA and 0.09% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Production & Epitope
Antibody was affinity purified using an epitope specific to Nucleolin immobilized on solid support.
The epitope recognized by IHC-00083 maps to a region between residue 550 and the C-terminus (residue 710) of human Nucleolin using the numbering given in entry NP_005372.2 (GeneID 4691).
Applications
Epitope exposure is recommended.
Immunohistochemistry (IHC)1:100 - 1:500
Documents
Safety Data SheetPDF · IHC-00083Open
Product DatasheetPDF · IHC-00083 · Lot 1 (current lot)Open
Product DatasheetPDF · IHC-00083 · Lot 1 (current lot)Open
Citations / Publications
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



